Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 296, Issue 2, 2009, Pages

  Shi, Tong ^a,c   Moulton, Vaishali R ^a   Lapchak, Peter H ^a   Deng, Guo Min ^a   Dalle Lucca, Jurandir J ^b   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Complement; Cytochalasin D; Deposition

Indexed keywords

BETA ACTIN; COMPLEMENT COMPONENT C3; CYTOCHALASIN D; IMMUNOGLOBULIN M;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CYTOSKELETON; DOSE RESPONSE; DRUG MEGADOSE; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; INTESTINE INJURY; INTESTINE ISCHEMIA; KINETICS; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; REPERFUSION INJURY;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C3D; CYTOCHALASIN D; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; IMMUNOGLOBULIN M; ISCHEMIA; JEJUNUM; MALE; MICE; MICE, INBRED C57BL; MICROFILAMENTS; REPERFUSION INJURY;

EID: 59449084415     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.90607.2008     Document Type: Article

References (51)

1. Arras M, Autenried P, Rettich A, Spaeni D, Rulicke T. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. Comp Med 51: 443-456, 2001.
2. Austen WG Jr, Kyriakides C, Favuzza J, Wang Y, Kobzik L, Moore FD Jr, Hechtman HB. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex. Surgery 126: 343-348, 1999.
3. Austen WG Jr, Zhang M, Chan R, Friend D, Hechtman HB, Carroll MC, Moore FD Jr. Murine hindlimb reperfusion injury can be initiated by a self-reactive monoclonal IgM. Surgery 136: 401-406, 2004.
4. Balasubramanian K, Schroit AJ. Characterization of phosphatidyl-serine-dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J Biol Chem 273: 2927229277, 1998.
5. Blikstad I, Markey F, Carlsson L, Persson T, Lindberg U. Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I. Cell 15: 935-943, 1978.
6. Bramlett HM, Dietrich WD. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 24: 133-150, 2004.
7. Bresnick AR. Molecular mechanisms of nonmuscle myosin-II regulation. Curr Opin Cell Biol 11: 26-33, 1999.
8. Brewster DC, Franklin DP, Cambria RP, Darling RC, Moncure AC, Lamuraglia GM, Stone WM, Abbott WM. Intestinal ischemia complicating abdominal aortic surgery. Surgery 109: 447-454, 1991.
9. Busch GJ, Martins AC, Hollenberg NK, Wilson RE, Colman RW. A primate model of hyperacute renal allograft rejection. Am J Pathol 79: 31-56, 1975.
10. Casella JF, Flanagan MD, Lin S. Cytochalasin D inhibits actin polymerization and induces depolymerization of actin filaments formed during platelet shape change. Nature 293: 302-305, 1981.
11. Craig SW, Powell LD. Regulation of actin polymerization by villin, a 95,000 dalton cytoskeletal component of intestinal brush borders. Cell 22: 739-746, 1980.
12. Crawford MH, Grover FL, Kolb WP, McMahan CA, O'Rourke RA, McManus LM, Pinckard RN. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation 78: 1449-1458, 1988.
13. Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC, Shea-Donohue T. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 90: 266-275, 1999.
14. Fleming SD, Egan RP, Chai C, Girardi G, Holers VM, Salmon J, Monestier M, Tsokos GC. Anti-phospholipid antibodies restore mesen-teric ischemia/reperfusion-induced injury in complement receptor 2/com-plement receptor 1-deficient mice. J Immunol 173: 7055-7061, 2004.
15. Fleming SD, Mastellos D, Karpel-Massler G, Shea-Donohue T, Lam-bris JD, Tsokos GC. C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin Immunol 108: 263-273, 2003.
16. ++-dependent nucleation and capping of the barbed end. Cell 24:471-480, 1981.
17. Hill JH, Ward PA. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 133: 885-900, 1971.
18. Huang J, Kim LJ, Mealey R, Marsh HC Jr, Zhang Y, Tenner AJ, Connolly ES Jr, Pinsky DJ. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 285: 595-599, 1999.
19. Kayalar C, Ord T, Testa MP, Zhong LT, Bredesen DE. Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. Proc Natl Acad Sci USA 93: 2234-2238, 1996.
20. Keith MP, Moratz C, Egan R, Zacharia A, Greidinger EL, Hoffman RW, Tsokos GC. Anti-ribonucleoprotein antibodies mediate enhanced lung injury following mesenteric ischemia/reperfusion in Rag-1(-/-) mice. Autoimmunity 40: 208-216, 2007.
21. Kellerman PS, Clark RA, Hoilien CA, Linas SL, Molitoris BA. Role of microfilaments in maintenance of proximal tubule structural and functional integrity. Am J Physiol Renal Fluid Electrolyte Physiol 259: F279-F285, 1990.
22. Kuhne W, Besselmann M, Noll T, Muhs A, Watanabe H, Piper HM. Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells. Am J Physiol Heart Circ Physiol 264: H1599-H1608, 1993.
23. Kwon O, Phillips CL, Molitoris BA. Ischemia induces alterations in actin filaments in renal vascular smooth muscle cells. Am J Physiol Renal Physiol 282: F1012-F1019, 2002.
24. Lindberg U. Purification from calf spleen of two inhibitors of deoxyri-bonuclease. I. Physical and chemical characterization of the inhibitor II. Biochemistry 6: 323-335, 1967.
25. Maclean D, Fishbein MC, Braunwald E, Maroko PR. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion. J Clin Invest 61: 541-551, 1978.
26. Manfredi AA, Rovere P, Heltai S, Galati G, Nebbia G, Tincani A, Balestrieri G, Sabbadini MG. Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein I. Arthritis Rheum 41: 215-223, 1998.
27. Maroko PR, Carpenter CB, Chiariello M, Fishbein MC, Radvany P, Knostman JD, Hale SL. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest 61: 661-670, 1978.
28. Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14: 1007-1012, 1997.
29. Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskel-etal actin plays a positive role in the process of morphological apoptosis. Oncogene 18: 2423-2430, 1999.
30. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660, 1993.
31. Molitoris BA, Dahl R, Geerdes A. Role of the actin cytoskeleton in ischemic injury. Chest 101: 52S-53S, 1992.
32. +-ATPase from its surface membrane actin cytoskeletal complex during cellular ATP depletion. J Clin Invest 88: 462-469, 1991.
33. Mortensen K, Larsson LI. Effects of cytochalasin D on the actin cytoskeleton: association of neoformed actin aggregates with proteins involved in signaling and endocytosis. Cell Mol Life Sci 60: 1007-1012, 2003.
34. Rampal AL, Pinkofsky HB, Jung CY. Structure of cytochalasins and cytochalasin B binding sites in human erythrocyte membranes. Biochemistry 19: 679-683, 1980.
35. Rao JY, Jin YS, Zheng Q, Cheng J, Tai J, Hemstreet GP, 3rd. Alterations of the actin polymerization status as an apoptotic morphological effector in HL-60 cells. J Cell Biochem 75: 686-697, 1999.
36. Schafer H, Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 137: 1945-1949, 1986.
37. Schliwa M. Action of cytochalasin D on cytoskeletal networks. J Cell Biol 92: 79-91, 1982.
38. Schwartz N, Hosford M, Sandoval RM, Wagner MC, Atkinson SJ, Bamburg J, Molitoris BA. Ischemia activates actin depolymerizing factor: role in proximal tubule microvillar actin alterations. Am J Physiol Renal Physiol 276: F544-F551, 1999.
39. Stahl GL, Xu Y, Hao L, Miller M, Buras JA, Fung M, Zhao H. Role for the alternative complement pathway in ischemia/reperfusion injury. Am J Pathol 162: 449-455, 2003.
40. Stossel TP. On the crawling of animal cells. Science 260: 1086-1094, 1993.
41. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM. Lack of a functional alternative complement pathway ameliorates isch-emic acute renal failure in mice. J Immunol 170: 1517-1523, 2003.
42. Tsokos GC, Fleming SD. Autoimmunity, complement activation, tissue injury and reciprocal effects. Curr Dir Autoimmun 7: 149-164, 2004.
43. Wakatsuki T, Schwab B, Thompson NC, Elson EL. Effects of cytocha-lasin D and latrunculin B on mechanical properties of cells. J Cell Sci 114: 1025-1036, 2001.
44. Weiser MR, Williams JP, Moore FD Jr, Kobzik L, Ma M, Hechtman HB, Carroll MC. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183: 23432348, 1996.
45. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249: 146-151, 1990.
46. Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, Wrenn JT, Yamaa K. Microfilaments in cellular and developmental processes. Science 171: 135-143, 1971.
47. Whisnant JP. Epidemiology of stroke: emphasis on transient cerebral ischemia attacks and hypertension. Stroke 5: 68-70, 1974.
48. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, Moore FD Jr, Carroll MC, Hechtman HB. Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86: 938-942, 1999.
49. Zhang M, Alicot EM, Chiu I, Li J, Verna N, Vorup-Jensen T, Kessler B, Shimaoka M, Chan R, Friend D, Mahmood U, Weissleder R, Moore FD, Carroll MC. Identification of the target self-antigens in reperfusion injury. J Exp Med 203: 141-152, 2006.
50. Zhang M, Austen WG Jr, Chiu I, Alicot EM, Hung R, Ma M, Verna N, Xu M, Hechtman HB, Moore FD Jr, Carroll MC. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 101: 3886-3891, 2004.
51. Zhou W, Farrar CA, Abe K, Pratt JR, Marsh JE, Wang Y, Stahl GL, Sacks SH. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 105: 1363-1371, 2000.